T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
NB Bancorp
NBBK
$1B
| $783K | ﹤0.01% |
39,493
+20,933
| +113% | +$398K |
|
2177
PRA Group
PRAA
$762M
| $780K | ﹤0.01% |
44,072
+7,178
| +19% | +$112K |
|
2178
Prothena Corp
PRTA
$475M
| $779K | ﹤0.01% |
81,515
+2,968
| +4% | +$30.2K |
|
|
SAFE
2179
Safehold
SAFE
$1.09B
| $778K | ﹤0.01% |
56,784
+1,520
| +3% | +$21.6K |
|
2180
United States Lime & Minerals
USLM
$3.42B
| $777K | ﹤0.01% |
6,482
+574
| +10% | +$71.2K |
|
2181
AMN Healthcare
AMN
$1.34B
| $775K | ﹤0.01% |
49,113
+7,123
| +17% | +$127K |
|
2182
Sweetgreen
SG
$693M
| $775K | ﹤0.01% |
114,524
-4,207,695
| -97% | -$28.9M |
|
2183
Tootsie Roll Industries
TR
$3.05B
| $775K | ﹤0.01% |
21,788
+213
| +1% | +$8.07K |
|
|
SILA
2184
DELISTED
Sila Realty Trust
SILA
| $774K | ﹤0.01% |
33,193
+3,506
| +12% | +$82.4K |
|
2185
The RMR Group
RMR
$337M
| $772K | ﹤0.01% |
51,774
+7,447
| +17% | +$113K |
|
|
SFIX
2186
Stitch Fix
SFIX
$487M
| $772K | ﹤0.01% |
147,034
+6,841
| +5% | +$31.2K |
|
2187
Teekay Tankers
TNK
$2.81B
| $770K | ﹤0.01% |
14,407
+1,314
| +10% | +$73.8K |
|
|
WSR
2188
DELISTED
Whitestone REIT
WSR
| $770K | ﹤0.01% |
55,394
+2,989
| +6% | +$38.5K |
|
2189
Hercules Capital
HTGC
$3.11B
| $767K | ﹤0.01% |
40,719
+2,594
| +7% | +$46.8K |
|
|
USAR
2190
USA Rare Earth Inc
USAR
$4.55B
| $767K | ﹤0.01% |
+64,450
| New | +$1.23M |
|
|
ZEUS
2191
DELISTED
Olympic Steel
ZEUS
| $766K | ﹤0.01% |
17,883
+1,962
| +12% | +$70K |
|
2192
Driven Brands
DRVN
$2.05B
| $764K | ﹤0.01% |
51,492
+5,812
| +13% | +$86.5K |
|
2193
MBIA
MBI
$254M
| $764K | ﹤0.01% |
106,605
+2,900
| +3% | +$21K |
|
2194
Zymeworks
ZYME
$1.77B
| $758K | ﹤0.01% |
28,784
+1,968
| +7% | +$42.9K |
|
2195
Ducommun
DCO
$3.04B
| $757K | ﹤0.01% |
7,951
+413
| +5% | +$38.5K |
|
2196
Liberty Broadband Class A
LBRDA
$5.07B
| $757K | ﹤0.01% |
15,671
+539
| +4% | +$27.9K |
|
2197
LGI Homes
LGIH
$1.32B
| $755K | ﹤0.01% |
17,559
-2,341
| -12% | -$110K |
|
2198
Red Violet
RDVT
$1.11B
| $754K | ﹤0.01% |
13,236
+680
| +5% | +$36.9K |
|
2199
Green Plains
GPRE
$1.06B
| $752K | ﹤0.01% |
76,662
+2,642
| +4% | +$26.6K |
|
2200
NETGEAR
NTGR
$658M
| $750K | ﹤0.01% |
30,547
-9,098
| -23% | -$262K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.